Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 5
1982 6
1983 3
1984 10
1985 10
1986 7
1987 11
1988 20
1989 23
1990 23
1991 27
1992 24
1993 12
1994 12
1995 23
1996 17
1997 14
1998 21
1999 21
2000 12
2001 15
2002 8
2003 6
2004 5
2005 14
2006 12
2007 5
2008 9
2009 9
2010 5
2011 16
2012 10
2013 6
2014 5
2015 10
2016 10
2017 11
2018 7
2019 4
2020 8
2021 8
2022 10
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

483 results

Results by year

Filters applied: . Clear all
Page 1
Botulinum toxin-induced blepharoptosis: Anatomy, etiology, prevention, and therapeutic options.
Nestor MS, Han H, Gade A, Fischer D, Saban Y, Polselli R. Nestor MS, et al. J Cosmet Dermatol. 2021 Oct;20(10):3133-3146. doi: 10.1111/jocd.14361. Epub 2021 Aug 11. J Cosmet Dermatol. 2021. PMID: 34378298 Free PMC article. Review.
Administration of medications, such as oxymetazoline hydrochloride or apraclonidine hydrochloride eye drops, anticholinesterase agents, or transdermal BoNT-A injections to the pre-tarsal orbicularis, can at least partially reverse eyelid ptosis. ...
Administration of medications, such as oxymetazoline hydrochloride or apraclonidine hydrochloride eye drops, anticholinesteras …
Apraclonidine.
[No authors listed] [No authors listed] 2021 Sep 20. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2021 Sep 20. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000720 Free Books & Documents. Review.
No information is available on the use of apraclonidine during breastfeeding. To substantially diminish the amount of drug that reaches the breastmilk after using eye drops, place pressure over the tear duct by the corner of the eye for 1 minute or more, then remove the ex …
No information is available on the use of apraclonidine during breastfeeding. To substantially diminish the amount of drug that reach …
Apraclonidine in the treatment of ptosis.
Wijemanne S, Vijayakumar D, Jankovic J. Wijemanne S, et al. J Neurol Sci. 2017 May 15;376:129-132. doi: 10.1016/j.jns.2017.03.025. Epub 2017 Mar 16. J Neurol Sci. 2017. PMID: 28431598
Currently there is no treatment available for BoNT induced ptosis. Apraclonidine hydrochloride is a topical ophthalmic solution with selective alpha-2 and weak alpha-1 receptor agonist activity that has the ability to elevate the eye lid. Apraclonidine has be …
Currently there is no treatment available for BoNT induced ptosis. Apraclonidine hydrochloride is a topical ophthalmic solutio …
Apraclonidine and my pupil.
Cambron M, Maertens H, Crevits L. Cambron M, et al. Clin Auton Res. 2011 Oct;21(5):347-51. doi: 10.1007/s10286-011-0118-6. Epub 2011 Mar 8. Clin Auton Res. 2011. PMID: 21384091 Clinical Trial.
Recent literature suggests that in healthy volunteers, apraclonidine provokes a mild miotic effect. Since the comparison of both the pathologic and the non-pathologic eye is important, we wanted to further investigate the effect of apraclonidine on the healthy eye. …
Recent literature suggests that in healthy volunteers, apraclonidine provokes a mild miotic effect. Since the comparison of both the …
Apraclonidine hydrochloride in vitreoretinal surgery.
Pulido JS, Mallick KS, Sneed SR, Blodi CF. Pulido JS, et al. Arch Ophthalmol. 1989 Mar;107(3):316-7. doi: 10.1001/archopht.1989.01070010326005. Arch Ophthalmol. 1989. PMID: 2647063 No abstract available.
Apraclonidine and LASIK.
Aslanides IM, Tsiklis NS, Pallikaris IG, Jankov MR, Coskunseven E, Ozkilic E. Aslanides IM, et al. Ophthalmology. 2005 Dec;112(12):2238; author reply 2244. doi: 10.1016/j.ophtha.2005.09.021. Ophthalmology. 2005. PMID: 16325717 Clinical Trial. No abstract available.
Topical apraclonidine hydrochloride in eyes with poorly controlled glaucoma. The Apraclonidine Maximum Tolerated Medical Therapy Study Group.
Robin AL, Ritch R, Shin D, Smythe B, Mundorf T, Lehmann RP. Robin AL, et al. Trans Am Ophthalmol Soc. 1995;93:421-38; discussion 439-41. Trans Am Ophthalmol Soc. 1995. PMID: 8719690 Free PMC article. Clinical Trial.
OBJECT: We determined whether the addition of topical apraclonidine hydrochloride to eyes receiving maximal medical therapy, with inadequate intraocular pressure (IOP) control, and scheduled to undergo surgery, could adequately lower IOP, postponing the need for sur …
OBJECT: We determined whether the addition of topical apraclonidine hydrochloride to eyes receiving maximal medical therapy, w …
Treatment of blepharospasm with apraclonidine.
Vijayakumar D, Wijemanne S, Jankovic J. Vijayakumar D, et al. J Neurol Sci. 2017 Jan 15;372:57-59. doi: 10.1016/j.jns.2016.11.029. Epub 2016 Nov 15. J Neurol Sci. 2017. PMID: 28017248
We propose that apraclonidine may be a useful short-term treatment in patients with blepharospasm, particularly during wearing off from botulinum toxin injection. METHODS: Patients who had pre-mature wearing off of botulinum injection effect were evaluated before and after …
We propose that apraclonidine may be a useful short-term treatment in patients with blepharospasm, particularly during wearing off fr …
Apraclonidine hydrochloride: an evaluation of plasma concentrations, and a comparison of its intraocular pressure lowering and cardiovascular effects to timolol maleate.
Robin AL, Coleman AL. Robin AL, et al. Trans Am Ophthalmol Soc. 1990;88:149-59; discussion 159-62. Trans Am Ophthalmol Soc. 1990. PMID: 1982747 Free PMC article. Clinical Trial.
We evaluated both the cardiovascular and IOP effects of both timolol maleate and apraclonidine hydrochloride. In addition, we evaluated the plasma levels of various apraclonidine concentrations. We utilized 0.5% timolol and both the 0.25% and 0.50% concentrat …
We evaluated both the cardiovascular and IOP effects of both timolol maleate and apraclonidine hydrochloride. In addition, we …
Short-term efficacy of apraclonidine hydrochloride added to maximum-tolerated medical therapy for glaucoma. Apraclonidine Maximum-Tolerated Medical Therapy Study Group.
Robin AL, Ritch R, Shin DH, Smythe B, Mundorf T, Lehmann RP. Robin AL, et al. Am J Ophthalmol. 1995 Oct;120(4):423-32. doi: 10.1016/s0002-9394(14)72655-8. Am J Ophthalmol. 1995. PMID: 7573299 Clinical Trial.
PURPOSE: We determined whether the addition of topical apraclonidine hydrochloride to eyes that are receiving maximal medical therapy but still have inadequate intraocular pressure control and that are scheduled to undergo surgery could adequately decrease intraocul …
PURPOSE: We determined whether the addition of topical apraclonidine hydrochloride to eyes that are receiving maximal medical …
483 results